On July 24, 2024, Remegen (09995) announced that the Board of Directors has passed the proposal of "Adjustment of the Plan for Issuing Stocks to Specific Objects", in which the company has adjusted the raised funds and relevant matters of this issuance plan.
Before the adjustment, the total amount of money raised from issuing stocks to specific objects in this offering does not exceed 2.55 billion yuan (including the current number); after the adjustment, the total amount of money raised from issuing stocks to specific objects in this offering does not exceed about 1.953 billion yuan (including the current number), and the net proceeds will be used for the new drug R&D project.